Article
Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Pharmacogenetics and genomics - 1 Mar 2006
Chen Xiaoping, Wang Haijian, Xie Weimin, Liang Renxiang, Wei Zhongliang, Zhi Lianteng, Zhang Xiumei, Hao Bingtao, Zhong Shaofei, Zhou Gangqiao, Zhang Lingqiang, Gao Xue, Zhu Yunping, He Fuchu
Abstract excerpt
OBJECTIVES: Aflatoxin B1 exposure is one of the major risk factors for hepatocellular carcinoma (HCC). CYP1A2 is a cytochrome P450 isoenzyme that plays an important role in the bioactivation of AFB1 to its carcinogenic metabolite. The study was designed to assess whether genetic polymorphisms in CYP1A2 are associated with HCC susceptibility in a high-risk region. METHODS: A case-control study of 431 HCC cases and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
